Comparative Assessment of Clinical Efficacy of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

Trial Profile

Comparative Assessment of Clinical Efficacy of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jan 2016

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 22 Jul 2011 Planned end date changed from 1 May 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top